Jessica Davis
Principal at AVANT BIO
New York, New York
Overview
Work Experience
Principal
2023 - Current
Avant Bio is an early-stage and growth equity firm investing across Life Sciences, TechBio, Healthtech and Diagnostics. As Principal, I support deal sourcing and diligence, portfolio operations, and investor relations.
Principal
2022
Senior Associate
2021 - 2022
Venture Associate
2020 - 2021
Board Observer
2022
Vernal Biosciences specializes in high-purity mRNA for research and clinical use.
Raised $41,000,000.00 from Ampersand Capital Partners, Dynamk Capital, Vermont Center for Emerging Technologies, Charles River Laboratories International, Dynamk Capital, Alloy Therapeutics, Ampersand Capital Partners, ATUM and Charles River Laboratories International.
Board Observer
2022
Board Observer
2021
Board Observer
2021
Member
2021
InSITE Fellow
2020 - 2021
A highly competitive leadership development program comprised of exceptional graduate students at top universities
Consultant
2016 - 2019
- Change Management & Project Management Lead for Acquisition: Managed Change Management workstream and Program Management for internal team members and external client resources. Analyzed people and process impacts across front and back office business functions for multiple end-user stakeholders and developed organization assessment to document impacts to existing operations. Calculated cost to develop training materials and train resources; created Change Management timeline to indicate timing of new process development and training course dates. Established Program Management cadence, roles and responsibilities for 30+ client resources. - M&A Due Diligence and Risk Assessment: Developed detailed timeline and roadmap of integration planning activities through deal close and analyzed significant operational and integration risks for Buyer. - Operating Model & Organization Design Process Improvement: Assessed divisional operating model of 50+ resources to conduct current state analysis, document process, system and resource improvements and design future state organization based on recommendations.
Senior Business Analyst
2015 - 2016
• Completed operating expense budget reconciliation and supported cost savings portfolio management at large state payer. Assessed $1B+ enterprise budget and developed recommendations for future budget reductions. Collaborated with C-suite leadership to identify $90M+ in cost savings opportunities. Developed improved governance model and value tracking process. Supported implementation and project management to help client achieve annual savings target of $75M. • Supported analytic performance improvement at large payer to identify key performance metrics. Completed current vs. future state gap analyses, defined future state metrics and developed implementation roadmap. • Supported strategic business transformation value assessment at large payer to identify $96M of potential value from enterprise-wide opportunities. Validated business engagement with stakeholders, defined high-level value estimates from potential enterprise transformations • Analyzed EMR data collection processes to develop future state improvements and recommend means to increase value gained from data acquisition. Identified $62M+ in potential savings from HEDIS & RSA data collection. Was responsible for business process flows and tracking status of data from provider organizations.
Business Analyst
2014 - 2015
-Federal contractor for the Department of Defense -Designed and implemented multiple work plans and scenarios to improve performance -Supported the department's efforts to maintain efficiency and flexibility with current planning systems -Analyzed and provided recommendations on processes and applications for current and future contracts
Accenture Ventures is a venture capital firm arm of Accenture, delivers innovative solutions with strategic partnerships and investments.
Student
2010 - 2014
Middlebury Women's Crew Team, Biology Department Student Advisory Council, YouPower Spinning Instructor